United States

Jesse Palmer Throws a "Season Pass" at Influenza Awareness to College Students Nationwide

ESPN Sportscaster and Former Pro Football Player Urges Students to Get Seasonal Flu Shot

King of Prussia, PA — 11/14/2008



Click to play video 0:31
To increase flu vaccination rates among college students, CSL Biotherapies is partnering on Season Pass© with Jesse Palmer, ESPN co-host of "College Football Live" and former pro football player. Season Pass is a novel program designed to immunize as many college students as possible during the 2008-2009 influenza (flu) season. College students are at risk for contracting the flu due to their close living quarters and frequent contact with other students. Season Pass aims to educate college students about influenza prevention and motivate them to visit their on-campus health center to get vaccinated.

"We want college students around the country to avoid getting sidelined by the flu," said Palmer. "Classrooms and dorms are the perfect environments for spreading the flu. So, we are getting the word out that receiving a flu shot is the best defensive strategy to tackle the virus before it blocks you from your game." Palmer is a former NFL quarterback for the NY Giants and San Francisco 49ers.

The Season Pass campaign began at Arizona State University (ASU) as a pilot initiative organized by the ASU Campus Health Center during the 2007-08 flu season. It consisted of two week-long flu vaccine clinics on-campus and giveaway items. The program successfully increased by 70 percent the number of vaccinations that were administered on the ASU campus during the 2007-2008 flu season. This season, the program is being expanded to select universities across the U.S.

"College life is extremely busy and stressful for students," said Allan L. Markus, MD, Clinical Associate Professor of Medicine, University of Arizona College of Medicine in Phoenix in partnership with Arizona State University and Director of the Campus Health Service at Arizona State University. "Although they are at high risk for the flu, many college students don't get a flu shot because they may not be aware of the important health benefit it offers. Season Pass is geared toward educating students on the impact influenza can have on themselves and those around them and highlight the need for yearly immunization."

About the Season Pass Program
Season Pass is an easy-to-implement comprehensive program developed by CSL Biotherapies to promote a Flu-Free campus. The program features a free kit that includes fun-filled educational materials, which colleges and universities can use to implement and publicize on-campus flu immunization clinics. These flu immunization events can feature a series of flu vaccination days held at a college’s Student Union or in residential halls. The program can also be used to increase students’ flu vaccine demand at a Campus Health center, allowing better tracking of immunization records on campus. Season Pass provides ‘thank you’ giveaways to students and a postage-paid postcard that students can send home to inform parents they received a flu shot. An educational Public Service Announcement (PSA) featuring Jesse Palmer is also available online at: www.cslbiotherapies-us.com. This year, CSL Biotherapies has distributed more than 1,000 Season Pass kits to 600 colleges and universities nationwide. Information about access to this unique free program can be requested by sending an email to seasonpass@cslbiotherapies.com or by calling toll free 1-888-435-8633.

"Our goal with Season Pass is to decrease the burden of influenza on U.S. college campuses, where influenza illness is clearly identified as an impediment to academic performance," said Paul Perreault, Executive Vice President of CSL Biotherapies Worldwide Commercial Operations. "At CSL we remain committed to help improve influenza prevention among priority audiences. We believe that unique educational programs like Season Pass will help address some of these unmet needs."

About CSL Biotherapies
CSL Biotherapies is the leading manufacturer and global supplier of thimerosal-free (mercury-free), inactivated, trivalent influenza vaccine for adults. The U.S. headquarters of CSL Biotherapies is located in King of Prussia, Pa. Its parent company, CSL Limited, in Melbourne, Australia, operates one of the world's largest influenza vaccine facilities for global markets. CSL Biotherapies, which shares its U.S. headquarters with its sister company, CSL Behring, is commercializing influenza vaccine products globally. At CSL Biotherapies, delivering vaccines is our mission, protecting lives our passion. The CSL Group, which also includes CSL Research & Development, CSL Bioplasma, and CSL Behring, has more than 8,500 employees and operates in 21 countries worldwide. For more information, visit us at www.cslbiotherapies-us.com, or call 1-888-435-8633.

Media Contacts:

Sheila A. Burke
Director, Public Relations & Communications
Worldwide Commercial Operations
CSL Biotherapies
610-290-7403
Sheila.Burke@cslbiotherapies.com

Abenaa (Abby) Hayes
Weber Shandwick
212-445-8337
ahayes@webershandwick.com

The information presented on this site is intended for US residents only.
© 2017 Seqirus All rights reserved.
Seqirus is a trademark of CSL Limited.

BCSL14-02-0003 06/2014